Hemispherx Biopharma – Update Interview

Hemispherx Biopharma – Update Interview post image

Our original interest with Hemispherx Biopharma (HEB) was the fact that one of its experimental products was under active review with the United States Food and Drug Administration for the treatment of Chronic Fatigue Syndrome.

However, our interest in today’s interview is to discuss the recent events of the spread of swine influenza that is all over the news in recent days.

With us to discuss these events of the swine flu outbreak is Dr. William Carter, Chairman and CEO of Hemispherx Biopharma, Inc.

Click the start button underneath to listen to the interview.




Comments on this entry are closed.